ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells.

MLA

Carretero-Iglesia, Laura, et al. “ISB 2001 Trispecific T Cell Engager Shows Strong Tumor Cytotoxicity and Overcomes Immune Escape Mechanisms of Multiple Myeloma Cells.” Nature Cancer, vol. 5, no. 10, Oct. 2024, pp. 1494–514. EBSCOhost, https://doi.org/10.1038/s43018-024-00821-1.

APA

Carretero-Iglesia, L., Hall, O. J., Berret, J., Pais, D., Estoppey, C., Chimen, M., Monney, T., Loyau, J., Dreyfus, C., Macoin, J., Perez, C., Menon, V., Gruber, I., Laurendon, A., Caro, L. N., Gudi, G. S., Matsuura, T., van der Graaf, P. H., Blein, S., … Pihlgren, M. (2024). ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells. Nature Cancer, 5(10), 1494–1514. https://doi.org/10.1038/s43018-024-00821-1

Chicago

Carretero-Iglesia, Laura, Olivia J Hall, Jérémy Berret, Daniela Pais, Carole Estoppey, Myriam Chimen, Thierry Monney, et al. 2024. “ISB 2001 Trispecific T Cell Engager Shows Strong Tumor Cytotoxicity and Overcomes Immune Escape Mechanisms of Multiple Myeloma Cells.” Nature Cancer 5 (10): 1494–1514. doi:10.1038/s43018-024-00821-1.